ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EG02 | G | Everolimus - 2.5mg | 10481/388 | 2220/1 | EVEROLIMUS ARROW | 2.5mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | L.L | 10.71 | E1 | Arrow Génériques | France | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EG02 | G | Everolimus - 2.5mg | 11380 | 113021/1 | EVEROLIMUS BIOGARAN | 2.5mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | 52,290,378 L.L | 10.71 | E1 | Laboratoires Biogaran | France | 12/12/20 | 0 |
L01EG02 | G | Everolimus - 2.5mg | 10481 | 2220/1 | EVEROLIMUS ARROW | 2.5mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | 52,634,673 L.L | 10.71 | E1 | Arrow Génériques | France | 12/12/20 | 0 |